Association between interleukin 6 gene polymorphisms and Behçet ’ s disease in Korean people

T he paper of Mohr discussing the development of rice bodies with apatite crystals in fibrinous debris synovitis in rheumatoid arthritis prompted us to describe our recent morphological findings. During synovectomy in a 33 year old woman with a longlasting systemic form of juvenile idiopathic arthritis (JIA) a large number of rice bodies and numerous synovial villi connected to the synovial membrane (SM) by very thin stalks were visible in the joint space (JS). Light microscopy of paraffin sections showed that the villi contained fibrin and had degenerated. In the SM, mononuclear infiltration, neoangiogenesis, intimal layer hyperplasia, and fibrin at the synovial surface were found. Light microscopy of serial semithin resin sections enabled a distinction to be made between lymphatic capillaries (LC). Prominent LC were found under villous fibrin (fig 1A). In connective tissue around the LC, macrophages were seen. Cells and debris were rarely seen inside the lumina of the LC (fig 1B). LC were also seen in areas of the SM not covered with fibrin (fig 1C). These LC were situated in the subintimal connective tissue and were often surrounded by numerous mononuclear cells. In some of these LC, cells (mostly lymphocytes) were found. Kuhns presented a detailed morphological study of lymphatic drainage of synovial joints in rabbits. He discovered that inflammation in the synovial tissue decreased the ability of LC to absorb material larger than that of molecular size and presumed that persistent inflammation was, to a certain extent, dependent on the non-functioning of the lymphatic vessels. Later, Pullinger and Florey proved that LC proliferated in acute inflammation and repair. They demonstrated that LC proliferated also in chronic inflammation induced in the skin of mice, and emphasised that debris was removed from the damaged areas by the LC, either directly or by phagocytic cells. Recently, in rheumatoid arthritic synovium, debris and cells were seen inside the lumina of LC and, moreover, endothelial microvalves were visualised in the walls of the LC by transmission electron microscopy. Endothelial microvalves of LC probably have an important role in drainage of excessive tissue fluid, allowing cells and debris to be removed from SM connective tissue spaces into the lymph. The LC are an integral part of connective tissue, in which prelymphatic tissue channels have been described. 6 In the patient reported in this paper, fibrin deposition and mononuclear infiltration may have blocked part of the prelymphatic tissue channels in the SM, thus reducing the drainage of the JS. This might have contributed to the formation of rice bodies in synovial fluid (SF). Rice bodies in rheumatoid SF contain mononuclear cells, mostly macrophagic in appearance. Accumulation of rice bodies in the JS may contribute to increased cytokine levels in the SF. It is known that SF cytokines can modulate the level of vascular endothelial growth factor (VEGF) secretion. VEGF-C and D were shown to stimulate lymphangiogenesis. Recently, mature VEGF-C was found in rheumatoid arthritis synovial tissue.

[1]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. , 2010, Arthritis and rheumatism.

[2]  David G I Scott,et al.  Epidemiology of systemic vasculitis , 2005, Current rheumatology reports.

[3]  K. Kim,et al.  Endothelial nitric oxide synthase gene polymorphisms in Behçet’s disease and rheumatic diseases with vasculitis , 2003, Annals of the rheumatic diseases.

[4]  B. Dijkmans,et al.  Early changes in bone metabolism in rheumatoid arthritis patients treated with infliximab. , 2003, Arthritis and rheumatism.

[5]  M. Dougados,et al.  International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis , 2003, Annals of the rheumatic diseases.

[6]  W. Mohr On the origin of rice bodies with apatite crystals , 2003, Annals of the rheumatic diseases.

[7]  J. Braun,et al.  Treatment of active ankylosing spondylitis with pamidronate. , 2003, Rheumatology.

[8]  Tore K Kvien,et al.  Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) collaborative study. , 2003, Arthritis and rheumatism.

[9]  A. Dolan,et al.  Does active treatment of rheumatoid arthritis limit disease-associated bone loss? , 2002, Rheumatology.

[10]  W. Gross,et al.  Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus. , 2002, Arthritis and rheumatism.

[11]  A. Tenenbaum,et al.  Autoantibodies to Cardiolipin and Beta-2-Glycoprotein-I in Coronary Artery Disease Patients with and without Hypertension , 2002, Cardiology.

[12]  G. Jhangri,et al.  A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. , 2002, Arthritis and rheumatism.

[13]  D. Grainger,et al.  High titres of serum antinuclear antibodies, mostly directed against nucleolar antigens, are associated with the presence of coronary atherosclerosis , 2002, Annals of the rheumatic diseases.

[14]  A. Hamzaoui,et al.  Cytokine profile in Behçet's disease patients , 2002, Scandinavian journal of rheumatology.

[15]  F. Rigal,et al.  Localized polyarteritis nodosa with periostitis. , 2001, The Journal of rheumatology.

[16]  A. Tenenbaum,et al.  Coronary Artery Disease but Not Coronary Calcification Is Associated with Elevated Levels of Cardiolipin, Beta-2-Glycoprotein-I, and Oxidized LDL Antibodies , 2001, Cardiology.

[17]  S. Hancocks view from the chair: I go to a friend , 2001, British Dental Journal.

[18]  X. Marchandise,et al.  Factors influencing bone loss in rheumatoid arthritis: a longitudinal study. , 2000, Clinical and experimental rheumatology.

[19]  B. Dijkmans,et al.  Data driven attempt to create a clinical algorithm for identification of women with rheumatoid arthritis at high risk of osteoporosis , 2000, Annals of the rheumatic diseases.

[20]  F. Jessen,et al.  Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German population , 2000, Neuroscience Letters.

[21]  K. Pile,et al.  Evaluation of antibodies to beta2-glycoprotein 1 in the causation of coronary atherosclerosis as part of the antiphospholipid syndrome. , 1999, Australian and New Zealand journal of medicine.

[22]  P. Sham,et al.  Model-Free Analysis and Permutation Tests for Allelic Associations , 1999, Human Heredity.

[23]  C. Korkmaz,et al.  Sarcoidosis with palpable nodular myositis, periostitis and large-vessel vasculitis stimulating Takayasu's arteritis. , 1999, Rheumatology.

[24]  M. Rogers,et al.  Heterocycle‐Containing Bisphosphonates Cause Apoptosis and Inhibit Bone Resorption by Preventing Protein Prenylation: Evidence from Structure‐Activity Relationships in J774 Macrophages , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  J S Yudkin,et al.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.

[26]  D. Scott,et al.  Cutaneous vasculitis in a defined population--clinical and epidemiological associations. , 1998, The Journal of rheumatology.

[27]  S. van der Linden,et al.  Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis , 1997, The Lancet.

[28]  S. Ralston,et al.  Polymorphisms of the interleukin-6 gene are associated with bone mineral density , 1997, Osteoporosis International.

[29]  J. Rowe,et al.  Treatment of the neutropenia of Felty syndrome. , 1996, Blood reviews.

[30]  H. Sekihara,et al.  Interleukin-6 (IL-6) in patients with Behçet's disease. , 1996, Journal of dermatological science.

[31]  D. Scott,et al.  Epidemiology of systemic vasculitis: changing incidence or definition? , 1995, Seminars in arthritis and rheumatism.

[32]  R J Falk,et al.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference. , 1994, Arthritis and rheumatism.

[33]  J. Vicente,et al.  Microscopic rice bodies in rheumatoid synovial fluid sediments. , 1992, The Journal of rheumatology.

[34]  S. Ralston,et al.  Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. , 1990, BMJ.

[35]  A. Bowcock,et al.  Rapid detection and sequencing of alleles in the 3' flanking region of the interleukin-6 gene. , 1989, Nucleic acids research.

[36]  K. Kidd,et al.  The human "interferon-beta 2/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. , 1988, Genomics.

[37]  G. Hauck The connective tissue space in view of the lymphology , 1982, Experientia.

[38]  A. Silman,et al.  [Criteria of diagnosis of Behcet's disease]. , 1975, La Tunisie medicale.

[39]  A. H. Woodward,et al.  Periosteal new bone formation in polyarteritis nodosa: a syndrome involving the lower extremities. , 1974, Arthritis and rheumatism.

[40]  P. Saville Polyarteritis nodosa with new bone formation. , 1956, The Journal of bone and joint surgery. British volume.

[41]  H. Florey,et al.  Proliferation of lymphatics in inflammation , 1937 .

[42]  J. G. Kuhns LYMPHATIC DRAINAGE OF JOINTS , 1933 .

[43]  G. Haugeberg,et al.  Primary vasculitis in a Norwegian community hospital: A retrospective study , 2005, Clinical Rheumatology.

[44]  J. Neumüller,et al.  Structure of synovial lymphatic capillaries in rheumatoid arthritis and juvenile idiopathic arthritis. , 2003, International journal of tissue reactions.

[45]  M. Karkkainen,et al.  Molecular regulation of lymphangiogenesis and targets for tissue oedema. , 2001, Trends in molecular medicine.

[46]  A. Collins,et al.  The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. , 2000, Rheumatology.

[47]  E. Hess,et al.  Accelerated atherosclerosis and coronary disease in SLE. , 1997, Lupus.

[48]  Y. Shoenfeld,et al.  Emerging cross-regulatory roles of immunity and autoimmunity in atherosclerosis , 1996, Immunologic research.

[49]  Qingbo Xu,et al.  Is atherosclerosis an immunologically mediated disease? , 1995, Immunology today.

[50]  B. Haynes,et al.  Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. , 1983, Annals of internal medicine.

[51]  J. Casley‐Smith The fine structure of the microvasculature in inflammation. , 1979, Bibliotheca anatomica.